Related Experiment Videos
[Contraception using a progestagen-only minipill in cardiac patients]
Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 1, 1979
Summary
Microdosage lynoestrenol offers effective and safe contraception for cardiac patients. This mini-pill demonstrated excellent reversibility and was well-tolerated with no adverse cardiovascular or metabolic effects observed.
Area of Science:
- Cardiology
- Reproductive Endocrinology
Context:
- Combined oral contraceptives and IUDs are often contraindicated in cardiac patients.
- Contraception choice for women with heart conditions is limited.
Purpose:
- To evaluate the safety and efficacy of microdosage lynoestrenol as a contraceptive method for cardiac patients.
- To assess the impact of lynoestrenol on cardiovascular and metabolic parameters.
Summary:
- A study involving 40 cardiac patients, including 28 high-risk individuals, assessed daily, uninterrupted lynoestrenol (500 mcg) for 6-30 months.
- The mini-pill proved highly effective with excellent reversibility and acceptability, despite menstrual changes.
- No hemodynamic, hypersensitive, or thromboembolic side effects were noted. Metabolic and coagulation parameters remained stable in high-risk patients.
Impact:
- Microdosage lynoestrenol appears to be a safe and acceptable oral contraceptive option for cardiac patients.
- This finding is crucial for women with heart conditions requiring reliable contraception.
- Close cardiac monitoring and patient collaboration are essential for optimal outcomes.